<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: To study the effects of <z:chebi fb="2" ids="2948">azathioprine</z:chebi> alone and combined <z:chebi fb="2" ids="2948">azathioprine</z:chebi> and <z:chebi fb="0" ids="6888">methylprednisolone</z:chebi> on <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:e sem="disease" ids="C0265110" disease_type="Disease or Syndrome" abbrv="">cerebral vasospasm</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: An animal model of "double <z:hpo ids='HP_0002138'>subarachnoid hemorrhage</z:hpo>" was established by two cisterna magna injections of non-heparinized autologous arterial blood (0.3 ml/kg) </plain></SENT>
<SENT sid="2" pm="."><plain>The preventive effect of <z:chebi fb="2" ids="2948">azathioprine</z:chebi> alone and its combination with <z:chebi fb="0" ids="6888">methylprednisolone</z:chebi> on <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:e sem="disease" ids="C0265110" disease_type="Disease or Syndrome" abbrv="">cerebral vasospasm</z:e> was studied </plain></SENT>
<SENT sid="3" pm="."><plain>By angiography of vertebrobasilar artery with a transfemoral catheter, assay of LPO (<z:chebi fb="23" ids="18059">lipid</z:chebi> peroxidation) was performed on BA wall </plain></SENT>
<SENT sid="4" pm="."><plain><z:hpo ids='HP_0011010'>Chronic</z:hpo> <z:e sem="disease" ids="C0265110" disease_type="Disease or Syndrome" abbrv="">cerebral vasospasm</z:e> following <z:hpo ids='HP_0002138'>subarachnoid hemorrhage</z:hpo> was noted and the drugs' effect on <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:e sem="disease" ids="C0265110" disease_type="Disease or Syndrome" abbrv="">cerebral vasospasm</z:e> also observed </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: Seven days after subarachniod <z:mp ids='MP_0001914'>hemorrhage</z:mp>, the basilar arterial (BA) diameter was 87% +/- 26% of the original BA diameter, and LPO content of BA wall was 0.03 +/- 0.01 nmol/mg in <z:chebi fb="2" ids="2948">azathioprine</z:chebi> group and 93% +/- 20% (BA diameter) and 0.02 +/- 0.01 nmol/L (LPO content) in <z:chebi fb="2" ids="2948">azathioprine</z:chebi> plus <z:chebi fb="0" ids="6888">methylprednisolone</z:chebi> group </plain></SENT>
<SENT sid="6" pm="."><plain>When the BA diameter was 53% +/- 19%, the LPO content was 0.11 +/- 0.05 nmol/mg in the control group </plain></SENT>
<SENT sid="7" pm="."><plain>Pathological examination showed that <z:chebi fb="2" ids="2948">azathioprine</z:chebi> alone and its combination with <z:chebi fb="0" ids="6888">methylprednisolone</z:chebi> obviously reduced the damage to the BA wall </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSION: <z:chebi fb="2" ids="2948">Azathioprine</z:chebi> has preventive effect on <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:e sem="disease" ids="C0265110" disease_type="Disease or Syndrome" abbrv="">cerebral vasospasm</z:e>, supresses the production of free radicals and reduces damage to the BA wall following <z:hpo ids='HP_0002138'>subarachnoid hemorrhage</z:hpo> </plain></SENT>
<SENT sid="9" pm="."><plain>Combined <z:chebi fb="2" ids="2948">azathioprine</z:chebi> <z:chebi fb="0" ids="6888">methylprednisolone</z:chebi> has produces better effects when only lower dosage is used </plain></SENT>
</text></document>